Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results
SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2022 financial results after the U.S. financial markets close on Tuesday, August 9, 2022. Oncternal’s management will host a webcast at 2:00 p.m. PT (5:00 p.m. ET) to provide a comprehensive business update and discuss the Company’s financial results.
The live webcast of the call will be available online at investor.oncternal.com and the call will be archived there for at least 30 days.
About Oncternal Therapeutics